BiotechTube
Home/MDI Therapeutics/Gillian Dines
GD

Gillian Dines

Chief Executive Officer

MDI Therapeutics

Therapeutic Areas

FibrosisFibroproliferative Diseases

MDI Therapeutics Pipeline

DrugIndicationPhase
Oral PAI-1 InhibitorFibrosis and Fibroproliferative DiseasesPreclinical

Leadership Team at MDI Therapeutics

DA
Daniel A. Lawrence, PhD
Founder, Chairman of Clinical & Scientific Advisory Board
View full MDI Therapeutics profile